Advertisement
Advertisement
TOPIC

Mergers & Acquisitions

Mergers & Acquisitions
The latest news, analysis and opinion on Mergers & Acquisitions. In-depth analysis, industry insights and expert opinion.
China’s private sector

Rights to antibody drug from China’s Keymed change hands in US acquisition

Sichuan-based Keymed expects to receive up to US$320 million as a result of deal involving its autoimmune disease treatment licensed in 2024.

China’s Zijin Mining clinches US$2.6b Chifeng Gold takeover in expansion drive

Elon Musk misled Twitter shareholders, US jury finds

videocam

Ant Group subsidiary completes steps for Hong Kong retail brokerage takeover

Bright Smart shares surge after Ant Group’s Wealthiness and Prosperity completes reporting procedures required by Chinese authorities.

Advertisement
Advertisement
Advertisement
Help preserve 120 years of quality journalism.
SUPPORT NOW
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement